Irish Medication Safety Network

improve patient safety with medication use

  • Home
  • About Us
    • Who are the IMSN?
    • Attending Members
    • Terms of Reference
  • Publications & Alerts
  • Conference
    • 2025 Kilmainham
    • 2024 Dublin Castle (All-Island)
    • Previous Years
  • Engage with us
  • Members
    Discussion Forum
Select Page

Insulin (Best Practice Guidelines) v2

by IMSN | Jul 8, 2020 | Articles | 0 comments

The US Institute for Safe Medication Practices considers insulin to be one of the top 5 ‘high-alert’ medications i.e. drugs that bear a heightened risk of causing significant patient harm when they are used in error.

IMSN Insulin Best Practice Guidelines March 2020

Recent Posts

  • Speakers presentations at IMSN conference 2025 21 November 2025
  • Posters at IMSN 2025 21 November 2025
  • Irish Medication Safety Network (IMSN) Conference 2025: “All Grown Up – 18 Years of the IMSN” to take place at Royal Hospital Kilmainham, Dublin, 21 November 2025 19 November 2025
  • Falls and Medication (Briefing document) 4 November 2025
  • Safety Alert on Time Critical Medicines 17 September 2025

Every effort has been made to ensure the accuracy of the publications on this website. However, the IMSN cannot accept legal responsibility for any errors or omissions.

  • Facebook
  • Twitter
  • Google
  • RSS

Designed by Elegant Themes | Powered by WordPress